Targeting TRPM channels for cerebral ischemia-reperfusion injury

Dai-Qiang Liu1, Wei Mei1, Ya-Qun Zhou1

  • 1Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Insights

Transient receptor potential melastatin (TRPM) channels are key players in brain injury after stroke. Targeting these channels offers a promising therapeutic strategy for cerebral ischemia-reperfusion injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Cerebral ischemia-reperfusion (I/R) injury is a major cause of stroke-related disability.
  • Transient receptor potential melastatin (TRPM) channels are implicated in cellular damage pathways.
  • Understanding TRPM channel roles is crucial for developing neuroprotective therapies.

Purpose of the Study:

  • To review recent findings on TRPM channel involvement in cerebral I/R injury.
  • To explore the mechanisms linking TRPM channels to I/R pathophysiology.
  • To discuss therapeutic potential and challenges of targeting TRPM channels.

Main Methods:

  • Literature review of studies on TRPM channels and cerebral I/R injury.
  • Analysis of research investigating TRPM channel function in oxidative stress, mitochondrial dysfunction, inflammation, and calcium overload.
  • Synthesis of current knowledge on TRPM channel modulators in preclinical models.

Main Results:

  • TRPM channels contribute to oxidative stress and mitochondrial dysfunction during I/R.
  • TRPM channel activity exacerbates inflammation and calcium overload in the brain.
  • Evidence suggests TRPM channels are critical mediators of neuronal damage in I/R.

Conclusions:

  • TRPM channels are significant contributors to cerebral I/R injury.
  • Modulating TRPM channel activity presents a viable therapeutic avenue.
  • Further research is needed to overcome challenges in TRPM channel-targeted therapy for stroke.